识别英国腹部皮瓣乳房再造费用的差异
该研究基于英国全国临床偏好调查开展微观成本核算,评估自体乳房再造的费用差异来源及加速康复外科(ERAS)的影响。结果显示术后位置与住院时长、术前影像和皮瓣监测策略是费用差异的最大来源;采用ERAS的单位总费用显著低于未采用者(p < 0.05)。作者认为许多驱动费用差异的做法缺乏强临床优势证据,且多数单位DIEP的总费用可能超过国家报销收费标准。
要点
- 术后位置与住院时长、术前影像及皮瓣监测策略是费用差异的最大来源。
- 采用ERAS的单位总费用显著低于未采用者(p < 0.05)。
- 作者认为许多驱动费用差异的做法缺乏强临床优势证据。
核心结论
- 研究揭示英国乳房再造基于临床医生偏好存在显著费用差异。
- 许多驱动费用差异的做法缺乏任何临床优势的强证据。
- 在多数乃至所有单位,DIEP的总费用可能超过国家报销收费标准,尤其考虑即刻与双侧乳房再造及未来对称化手术的额外资源需求时。
- 作者认为单位应通过ERAS精简费用,同时也应有促进优质诊疗的切合实际的收费标准。
研究设计与样本
- 基于英国全国临床偏好调查(由参与英国乳房再造的大多数整形外科医生和麻醉医生完成)设计的微观成本核算研究。
- 费用估算从病房和手术室运行成本等宏观要素,细化至外科补片、麻醉药物和皮瓣监测设备。
主要发现
- 费用差异最大来源于术后位置与住院时长、术前影像和皮瓣监测策略。
- 整形外科医生费用从1282英镑到3141英镑不等,麻醉费用在32英镑至151英镑之间(不含薪酬)。
- 单位内每例费用差异估计高达893英镑。
- 采用ERAS的单位总费用显著低于未采用者(p < 0.05)。
临床怎么用
- 作者认为单位应通过ERAS精简费用。
- 作者认为应有促进优质诊疗的切合实际的收费标准。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To understand variation in the cost of autologous breast reconstruction in the UK, including identifying key areas of cost variability, differences between and within units and the impact of enhanced recovery protocols (ERAS). METHODS: A micro-costing study was designed based on the responses to a national survey of clinical preferences completed by the majority of plastic surgeons and anaesthetists involved in the UK. Detailed costs were estimated from macro elements such as ward and theatre running costs, down to that of surgical meshes, anaesthetic drugs and flap monitoring devices. RESULTS: The largest variation in cost arose from postoperative location and length of stay, preoperative imaging and flap monitoring strategies. Plastic surgeon costs varied from £1282 to £3141, whereas anaesthetic costs were between £32 and £151 (not including salary). Estimated cost variation within units was up to £893 per case. Units with ERAS had significantly lower total costs than those without (p < 0.05). CONCLUSION: This study reveals significant cost variation in breast reconstruction in the UK based on clinician preferences. Many areas of practice driving this variation lack strong evidence of any clinical advantage. The total cost of a deep inferior epigastric perforator in the majority, if not all units, likely surpasses the national tariff for reimbursement, particularly when considering additional resource demand for immediate and bilateral breast reconstruction, as well as future symmetrisation procedures. Whilst units should look to streamline costs through ERAS, there should also be a realistic tariff that promotes excellent care.
引用
- Kwasnicki RM, Irukulla M, Che Bakri NA, et al. Identifying variation in the cost of abdominally based breast reconstruction in the UK. J Plast Reconstr Aesthet Surg. 2023. PMID: 38096767. doi:10.1016/j.bjps.2023.11.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。